Andrea Schietinger

Andrea Schietinger, PhD is an Associate Member of the Immunology Program at Memorial Sloan Kettering Cancer Center. Dr. Schietinger aims to understand when, why, and how T cells become unresponsive to tumors. Her lab utilizes genetic cancer mouse models that mimic cancer development in patients to define the molecular and epigenetic mechanisms that are responsible for the failure to control and eliminate tumors. More recently, her lab has been interested to understand how T cells differentiate during the onset of autoimmunity such as Type 1 Diabetes, and specifically how the autoimmune T cell response is initiate and maintained.

Dr. Schietinger received her PhD from the University of Chicago and University of Munich and conducted her postdoctoral training at the University of Washington and the Fred Hutchinson Cancer Center. She joined Memorial Sloan Kettering Cancer Center in 2015.